title: Flow cytometric detection of receptors for interleukin-6 on bone marrow and peripheral blood cells of humans and rhesus monkeys.
abstract: The expression of receptors for interleukin-6 (IL-6) on human and rhesus monkey peripheral blood and bone marrow (BM) cells was examined by multiparameter flow cytometry after staining with biologically active, biotin-labeled human IL-6 and phycoerythrin-conjugated streptavidin. Consistent with the multiple biologic effects of IL-6 in stimulating immune functions and hematopoiesis, IL-6 receptors were detectable on a wide variety of cell types. In peripheral blood, IL-6 receptors were detectable on monocytes, granulocytes, and on CD4+ T lymphocytes but not on resting, CD19+ B lymphocytes and CD56+ natural killer (NK) cells. CD8+ T lymphocytes also expressed IL-6 receptors but at lower levels than CD4+ cells. The IL-6 receptors on granulocytes were only detectable after staining with high concentrations of biotin-IL-6, suggesting that most IL-6 receptors on these cells represent low-affinity sites. In contrast, IL-6 receptors on both CD4+ and CD8+ T lymphocytes were detectable at biotin-IL-6 concentrations as low as 10 pmol/L, indicating that these cells bind IL-6 with high affinity. IL-6 receptor expression patterns on rhesus monkey and human blood cells were very similar except that receptor levels on granulocytes were lower in humans than in rhesus monkeys. Similar differences in expression levels were observed for IL-6 receptors that were detectable on most granulocyte precursors in the mononuclear fraction of rhesus monkey and human bone marrow. In addition to these relatively mature cell types, IL-6 receptors were detectable on a large fraction of human and rhesus monkey BM blast cells that express the CD34 antigen. The presence of IL-6 receptors on CD34+ BM blast cells, which are the precursor cells of most, if not all, BM-derived blood cells, is consistent with the ability of IL-6, in conjunction with other cytokines, to stimulate immature hemopoietic cells in vitro and to promote blood cell production when administered in vivo.
authors.affiliation: Erasmus University, Department of Radiobiology, Rotterdam, The Netherlands.
authors.forename: A W
authors.initials: AW
authors.lastname: Wognum
authors.forename: F C
authors.initials: FC
authors.lastname: van Gils
authors.forename: G
authors.initials: G
authors.lastname: Wagemaker
mesh_terms: D000818:Animals; D001853:Bone Marrow / Q000737:chemistry*; D015496:CD4-Positive T-Lymphocytes / Q000737:chemistry; D002462:Cell Membrane / Q000737:chemistry; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D006098:Granulocytes / Q000737:chemistry; D006801:Humans; D007962:Leukocytes / Q000737:chemistry*; D016131:Lymphocyte Subsets / Q000737:chemistry; D008214:Lymphocytes / Q000737:chemistry; D008253:Macaca mulatta; D009000:Monocytes / Q000737:chemistry; D011971:Receptors, Immunologic / Q000032:analysis*; D019947:Receptors, Interleukin-6
chemical_list: D011971:Receptors, Immunologic; D019947:Receptors, Interleukin-6